Live
Endpoints NewsSupreme Court preserves mail access for abortion pillFierceBiotechAardvark to dig into phase 3 data early after FDA imposes holdSiemens HealthineersSiemens Healthineers Wins Key US Clearances As Valuation Gap Widens - simplywall.stBioNTechBioNTech’s Clinical and Corporate Overhaul: Cancer Data Improves as COVID Era Ends - AD HOC NEWSEvery GreenBiotech Just Hit Fast Forward. Is Europe’s Seed Sector Ready? - seedworld.comIQVIAIQVIA And Kexing Biopharm Advance Global Biosimilar Expansion Through AI Enabled Strategic Collaboration - BioPharma APACIlluminaCorvex Funds tied to Illumina (NASDAQ: ILMN) sell shares and partly unwind equity swaps - Stock TitanFierceBiotechChutes & Ladders—AC Immune CEO bids adieuEli LillyIs Eli Lilly Going To $1,100? - 24/7 Wall St.Clinical OMICsAI in Healthcare: Symposium InsightsFierceBiotechSignant Health buys Ametris to unite data streams in clinical trialsScienceDid this scientist go too far trying to save Ecuador’s wildlife?
FierceBiotech Mar 30, 2026

Merck dives into detailed phase 3 data showing PCSK9 pill easily outswims rivals

Merck dives into detailed phase 3 data showing PCSK9 pill easily outswims rivals

Original
Body unavailable. Use the original source.